Sport&Diabetes, a project co-founded by the Erasmus+ programme of the European Union, analysed the barriers and developed content that addresses the concerns of people living with diabetes, their carers and relatives, coaches, sports and gym teachers regarding engaging in sporting activities when living with diabetes.
A group of 17 leading European ophthalmologists and researchers have gathered together under Eurocondor, the European Consortium for the Early Treatment of Diabetic Retinopathy, with the aim of testing a new eye drop treatment that could prevent the development of diabetic retinopathy.
The key aim of the project is to aid EU Member States to develop, select and implement more cost-effective policies to improve chronic disease prevention and impact upon populations with the highest rates of premature deaths from chronic diseases and reduce health inequalities.
Manage Care's aim was to develop an innovative chronic care model applicable not only for diabetes, but also for other chronic diseases and to prevent costly complications and frailty in elderly with type 2 diabetes, enabling them to live independent, healthy and active lives as long as possible.
The EuRhythDia project looked at whehter lifestyle change to resent the internal clock can significantly reduce the risk of developing type 2 diabetes and cardiometabolic complications
Feel4diabetes (Families across Europe following a healthy lifestyle 4 diabetes prevention) is an EU-funded project aiming to develop, implement and evaluate an evidence-based and potentially cost-effective and scalable intervention programme to prevent type 2 diabetes across Europe, primarily focusing on families from vulnerable groups.
IDF Europe is a consortium member of Innovative Medicines Initiative 2 project, Trials@Home, which aims to reshape clinical trial design, conduct and operations, by developing and piloting standards, recommendations and tools for the definition and operationalization of decentralized clinical trials (DCTs) in Europe.
CarpeDiab aims to be an advanced service for type 2 diabetes management. The project, which has received funding from the European Union's Horizon 2020, expects to have an impact on the behaviour of patients and healthcare professionals to take full advantage of the possibility that technology opens.
IDF Europe is part of the four-year RECOGNISED project that will study the biological mechanisms that cause structural and functional alterations in the retina in people with type 2 diabetes, to determine whether these same pathways play a role in the events observed in the brain during the development of cognitive impairment and dementia.
The purpose of this Joint Action is to identify, exchange, scale-up and transfer best practices and effective interventions for chronic diseases, with a specific focus on health promotion and prevention, multi-morbidity and diabetes.
IDF Europe is part of the Horizon 2020 project DigiCare4You, which aims to improve the early prevention and management of T2D and hypertension (HTN). The project’s overall objective is to assess the scalability and transferability of an intersectoral, innovative person-centred solution involving digital tools, aimed at empowering families and integrating community care services in Europe for the prevention and management of T2D and HTN.
IDF Europe is part of the EU Horizon 2020-funded project “ISLET – Advancing Innovative Stem Cell-based Therapy for Diabetes in Europe”. The project aims to build and implement a new and innovative programme for producing and marketing human pluripotent stem cell (hPSC)-derived advanced therapy medicinal products (ATMPs) for the treatment of people living with T1D.